GRI Bio (GRI) Other Accumulated Expenses (2020 - 2022)

GRI Bio's Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $104000.0 for Q2 2022.

• In Q2 2022, Other Accumulated Expenses rose 14.29% year-over-year to $104000.0; the TTM figure through Jun 2022 stood at $104000.0 (up 14.29% YoY), while the FY2021 annual figure was $97000.0, down 7.62% from the prior year.
• Other Accumulated Expenses for Q2 2022 stood at $104000.0, up from $100000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $105000.0 in Q4 2020, with the low at $89000.0 in Q1 2021.
• The 3-year median for Other Accumulated Expenses is $97000.0 (2021), against an average of $97142.9.
• The sharpest annual moves came in 2021 and 2022: Other Accumulated Expenses fell 7.62% in 2021, then grew 14.29% in 2022.
• GRI Bio's Other Accumulated Expenses stood at $105000.0 in 2020, then dropped by 7.62% to $97000.0 in 2021, then increased by 7.22% to $104000.0 in 2022.
• Business Quant data shows GRI's Other Accumulated Expenses at $104000.0 in Q2 2022, $100000.0 in Q1 2022, and $97000.0 in Q4 2021.